Results 111 to 120 of about 62,812 (152)

Validation and Repeatability of Differential Light Sensitivity Measurements with the Novel MAIA Microperimetry Device. [PDF]

Ophthalmol Sci
Ansari G, Giudici NL, Cancian G, Rossouw P, Rui C, Rosso A, Gazzina S, Feltgen N, Pfau K, Pfau M.   +9 more
europepmc   +1 more source

Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study. [PDF]

BMJ Open
Parakh S, Gee H, Lim A, Vinod S, Wheeler C, Rooney B, Montgomery R, Harden S, Moore M, Lehman M, Bettington C, Moodie T, Barber J, Schmidt L, Dizon J, Leigh L, Oldmeadow C, Mitchell P, Hau E.   +18 more
europepmc   +1 more source

Group psychosocial interventions for anxiety, depression, and post-traumatic stress disorder in children and adolescents in low- and middle-income countries: A realist systematic review and meta-analysis of randomised controlled trials. [PDF]

PLOS Ment Health
Jokinen T, Abassi M, Hodsoll J, Atmore KH, Bonell C, Rose-Clarke K.   +5 more
europepmc   +1 more source

Adebrelimab in Small Cell Lung Cancer: From Current Advances to Emerging Combination Strategy and Challenge. [PDF]

Biologics
Yang H, Yang L, Liu Y, Wang L.
europepmc   +1 more source

In silico assessment of cellular damage from Lu-177, Ac-225, and Pb-212 therapeutic radionuclides. [PDF]

Med Phys
Chatzipapas KP, Papachristou K, Visvikis D, Incerti S, Hazle JD, Kagadis GC.   +5 more
europepmc   +1 more source

Head to head comparison of two PET/CT imaging agents, [¹⁸F]D3FSP ([¹⁸F]P16-129) and [¹⁸F]AV45, in patients with alzheimer's disease. [PDF]

EJNMMI Res
Alexoff D, Wong DF, Kuwabara H, Dannals RF, Ploessl K, Kung HF.   +5 more
europepmc   +1 more source

Time-Dependent Predictive Accuracy Metrics in the Context of Interval Censoring and Competing Risks. [PDF]

Biom J
Yang Z, Rizopoulos D, Newcomb LF, Erler NS.   +3 more
europepmc   +1 more source

First real-world clinical experience with [¹⁷⁷Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteria. [PDF]

Eur J Nucl Med Mol Imaging
Ling SW, de Lussanet de la Sablonière Q, Ananta M, de Blois E, Koolen SLW, Drexhage RC, Hofland J, Robbrecht DGJ, van der Veldt AAM, Verburg FA, Brabander T.   +10 more
europepmc   +1 more source

Longitudinal Improvements in Quality of Life Following Testosterone Replacement Therapy in Men with Biochemical and Symptomatic Testosterone Deficiency: a 12 Month Retrospective Observational Study in a Remote Digital Healthcare Setting in the United Kingdom

Johnson H, Clift A, Huang D, Foster J, El-Osta A.   +4 more
europepmc   +1 more source